Page 34 - Malaysian Journal of Health Promotion, Vol 4 (Supplementary 1) 2022

Malaysian Journal of Health Promotion, Vol 4 (Supplementary 1) 2022
th
rd
14 MOH-AMM Scientific Meeting 2022 in conjunction with 23 NIH Scientific Conference Abstract Book
SYMPOSIUM 4: COUNTERING NCDS THROUGH INNOVATIONS

MOBILE COMMUNICATION AND USE BEHAVIOUR OF THE URBAN POOR IN THE
DEVELOPING COUNTRY: A FIELD STUDY IN MALAYSIA

Professor Dr. Mahendhiran Sanggaran Nair
Sunway University

-ABSTRACT NOT AVAILABLE-

INNOVATION IN CANCER TREATMENT

Professor Leong Chee Onn
Institute for Research, Development and Innovation,
International Medical University

-ABSTRACT NOT AVAILABLE-

CARDIOVASCULAR DISEASES AND BREAST CANCER

Ms. Shridevi Subramaniam
Institute Clinical Research,
National Institutes of Health

There is growing evidence that the incidence of cardiovascular disease (CVD) is greater among
breast cancer survivors as compared to the general population. Anticancer therapies are one
of the major attributes of the increased risk of morbidity and mortality from CVD in breast
cancer patients. The risk of cardiac toxicities is further accentuated by baseline presence of
cardiovascular risk factors as well as cardiovascular diseases. Hence, screening for
cardiovascular risk factors and any cardiac-related diseases to identify breast cancer patients
who are at high risk of developing CVD is an important step before the administration of
adjuvant cancer therapies. Such knowledge on baseline cardiovascular risk profiles in newly
diagnosed breast cancer patients will allow safe planning of adjuvant cancer therapy and
assessment of the need for early cardiology referral for high-risk patients. As shown in recent
evidence, the burden of cardiovascular comorbidities at initial cancer diagnosis was very high
among Malaysian breast cancer patients, irrespective of age and cancer staging. The baseline
prevalence of hypertension was 47.8%. Close to 20% had diabetes mellitus or were obese.
Dyslipidaemia was present in 65.3% and about 20% had 3 and more cardiovascular risk factors.
Findings from this study highlight the compelling need for a structured collaboration between
the oncology and cardiology disciplines to improve cardiovascular outcomes following breast
cancer. The establishment of a cardio-oncology partnership will provide the framework for
optimizing care delivery, education, research and promotion of survivorship. Importantly in
our local setting, the conduct of research and its findings in this aspect will help pave way for
the development of the cardio-oncology discipline. It will also act as a stepping stone to set
up a prospective surveillance system of cardiovascular health among breast cancer patients
and ultimately aid in the reduction of cardiovascular morbidity and mortality following breast
cancer.

8